+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Enhanced cellular entry and efficacy of tat conjugates by rational design of the auxiliary segment



Enhanced cellular entry and efficacy of tat conjugates by rational design of the auxiliary segment



Molecular Pharmaceutics 11(3): 964-973



Conjugation with a cell penetrating peptide such as Tat presents an effective approach to improve the intracellular accumulation of molecules with low membrane permeability. This strategy, however, leads to a reduced cellular entry of molecules that can cross cell membrane effectively. We report here that covalent linkage of an additional hydrophobic unit that mimics a hydrophobic domain near the Tat sequence can further improve the cellular uptake of the parental conjugate into cancer cells regardless of the membrane permeability of the unconjugated molecule. Both fluorescent imaging and flow cytometry measurements confirmed the effect of palmitoylation on the increased internalization of the Tat conjugates with either 5-carboxyfluorescein (5-FAM), a nonmembrane penetrating dye, or doxorubicin, an anticancer cancer drug that can readily diffuse across cell membranes. In the case of the Tat-doxorubicin conjugate, palmitoylation improves the conjugate's anticancer activity in both drug sensitive and resistant cervical cancer cell lines. We further demonstrate that modification of a Tat-5-FAM conjugate with a hydrophobic quencher could not only efficiently quench the fluorescence outside of cancer cell but also facilitate its entry into MCF-7 breast cancer cells. These results highlight the importance of rational molecular design of using peptide conjugation chemistry in cancer therapeutics and diagnostics.

(PDF emailed within 0-6 h: $19.90)

Accession: 052982669

Download citation: RISBibTeXText

PMID: 24437690

DOI: 10.1021/mp400619v


Related references

Rational design, biophysical and biological characterization of site-specific antibody-tubulysin conjugates with improved stability, efficacy and pharmacokinetics. Journal of Controlled Release 236: 100-116, 2018

Towards rational design of RAD51-targeting prodrugs: platinumIV-artesunate conjugates with enhanced cytotoxicity against BRCA-proficient ovarian and breast cancer cells. Chemical Communications: -, 2018

Rational Design of Cancer Nanomedicine for Simultaneous Stealth Surface and Enhanced Cellular Uptake. Acs Nano 2019, 2019

Cellular uptake mechanism of an inorganic nanovehicle and its drug conjugates: Enhanced efficacy due to clathrin-mediated endocytosis. Bioconjugate Chemistry 17(6): 1411-1417, 2006

Structure-based rational design of prodrugs to enable their combination with polymeric nanoparticle delivery platforms for enhanced antitumor efficacy. Angewandte Chemie 53(43): 11532-7, 2015

Rational design of self-cleaving pre-tRNA-ribonuclease P RNA conjugates. Biochemistry 33(35): 10800-10808, 1994

Rational design of HIV-1 entry inhibitors. Methods in Molecular Biology 993: 185-204, 2013

Rational design of polymer drug conjugates for use as anticancer agents. Journal of Pharmacy & Pharmacology 47(12B): 1081, 1995

Rational design of novel HIV-1 entry inhibitors by RANTES engineering. Vaccine 26(24): 3008-3015, 2008

A guide to maximizing the therapeutic potential of protein-polymer conjugates by rational design. Chemical Society Reviews 47(24): 8998-9014, 2018

Rational design of a comprehensive cancer therapy platform using temperature-sensitive polymer grafted hollow gold nanospheres: simultaneous chemo/photothermal/photodynamic therapy triggered by a 650 nm laser with enhanced anti-tumor efficacy. Nanoscale 8(12): 6837-6850, 2016

Rational design of biotin-disulfide-coumarin conjugates: a cancer targeted thiol probe and bioimaging. Chemical Communications 50(23): 3044-3047, 2014

Rational design and synthesis of novel dibenzo[b,d]furan-1,2,3-triazole conjugates as potent inhibitors of Mycobacterium tuberculosis. European Journal of Medicinal Chemistry 71: 160-167, 2014

Cell-penetrating conjugates of coproporphyrins with oligoarginine peptides: rational design and application for sensing intracellular O2. Bioconjugate Chemistry 22(12): 2507-2518, 2012

Rational design of a CD4 mimic that inhibits HIV-1 entry and exposes cryptic neutralization epitopes. Nature Biotechnology 21(1): 71-76, 2002